Skip to main content
. 2010 Jan 27;17(3):325–334. doi: 10.1128/CVI.00435-09

TABLE 1.

Characteristics of the study participants and changes from 2006 to 2008

Parameter No. (%) of children in yr
P valuec
2006 2008
Age group (mo) NS
    <24 87 (14.2) 115 (19.1)
    24-35 123 (20.1) 108 (17.9)
    36-47 133 (21.8) 124 (20.6)
    48-50 162 (26.5) 140 (23.3)
    ≥60 106 (17.3) 115 (19.1)
    Overall 611 (100) 602 (100)
Sex NS
    Male 326 (53.4) 316 (52.5)
    Female 285 (46.6) 286 (47.5)
Antibiotic use in the past 3 mo 0.011
    No 557 (91.2) 570 (94.7)
    Yes 54 (8.8) 32 (5.3)
RTIa in the past 3 mo 0.016
    No 553 (90.5) 567 (94.2)
    Yes 58 (9.5) 35 (5.8)
PCV7b immunization (no. of doses) <0.001
    0 573 (93.8) 354 (58.8)
    1 17 (2.8) 11 (1.8)
    ≥2 21 (3.4) 237 (39.4)
No. of siblings < 6 yrs old
    0 303 (49.6) 279 (46.3) NS
    1 294 (48.1) 296 (49.2) NS
    ≥2 14 (2.3) 27 (4.5) NS
Passive smoking NS
    No 501 (82.0) 520 (86.4)
    Yes 110 (18.0) 82 (13.6)
Nasopharyngeal carriage per age group (mo) NS
    <24 71 (81.6) 96 (83.5)
    24-35 107 (87.0) 95 (88.0)
    36-47 103 (77.4) 97 (78.2)
    48-50 120 (74.1) 110 (78.6)
    ≥60 74 (69.8) 85 (73.9)
    Overall 475 (77.7) 483 (80.2)
a

RTI, upper respiratory tract infection.

b

PCV7, seven-valent pneumococcal conjugate vaccine.

c

P values are based on chi-square and Fisher's exact tests. NS, nonsignificant.